drug

BB-301

Phase 2updated 3mo ago

by $BNTC Benitec Biopharma Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying BB-301

phase2A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagiarecruitingn=30

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

BB-301

Phase 2updated 3mo ago

by $BNTC Benitec Biopharma Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying BB-301

phase2A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagiarecruitingn=30

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

BB-301

all catalysts(0)

Trials studying BB-301

News(0)

Report a data issue

comments(0)

BB-301

all catalysts(0)

Trials studying BB-301

News(0)

Report a data issue

comments(0)